£121.46

Springer Hereditary Tyrosinemia: Pathogenesis, Screening and Management: 959 (Advances in Experimental Medicine and Biology, 959)

Price data checked 5 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£121 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 86 days • 86 data points (No recent data available)

Historical
Generating forecast...
£121.46 £115.39 £117.82 £120.25 £122.67 £125.10 £127.53 08 April 2026 29 April 2026 20 May 2026 10 June 2026 02 July 2026

Price Distribution

Price distribution over 86 days • 1 price levels

Days at Price
86 days 0 22 43 65 86 £121 Days at Price

Price Analysis

Most common price: £121 (86 days, 100.0%)

Price range: £121 - £121

Price levels: 1 different prices over 86 days

Description

Hereditary tyrosinemia type 1 (HT1), the most severe inborn error of the tyrosine degradation pathway, is due to a deficiency in fumarylacetoacetate hydrolase (FAH). The worldwide frequency of HT1 is one per 100,000 births, but some regions have a significantly higher incidence (1:1,800). The FAH defect results in the accumulation of toxic metabolites, mainly in the liver. If left untreated, HT1 is usually fatal before the age of two. HT1 patients develop several chronic complications including cirrhosis with a high risk of hepatocellular carcinoma (HCC) and neuropsychological impairment. Treatment comprises an inhibitor of the pathway, Nitisinone, a strict dietary treatment or liver transplantation. Early treatment is important to avoid HCC. The book includes the latest developments on the molecular basis of HT1, its pathology, screening and diagnosis and management of the disease written by leading scientists, geneticists, hepatologists and clinicians in the field. From the Back Cover Hereditary tyrosinemia type 1 (HT1), the most severe inborn error of the tyrosine degradation pathway, is due to a deficiency in fumarylacetoacetate hydrolase (FAH). The worldwide frequency of HT1 is one per 100,000 births, but some regions have a significantly higher incidence (1:1,800). The FAH defect results in the accumulation of toxic metabolites, mainly in the liver. If left untreated, HT1 is usually fatal before the age of two. HT1 patients develop several chronic complications including cirrhosis with a high risk of hepatocellular carcinoma (HCC) and neuropsychological impairment. Treatment comprises an inhibitor of the pathway, Nitisinone, a strict dietary treatment or liver transplantation. Early treatment is important to avoid HCC. The book includes the latest developments on the molecular basis of HT1, its pathology, screening and diagnosis and management of the disease written by leading scientists, geneticists, hepatologists and clinicians in the field.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
10 August 2017
Listed Since
16 February 2017

Barcode

No barcode data available

Similar Products You Might Like

Springer - Autoimmune Liver Diseases: Perspectives from Japan
97% match

Springer - Autoimmune Liver Diseases: Perspectives from Japan

Springer

£102.53 20 Apr 2026
Autoimmune Liver Diseases: Perspectives from Japan
97% match

Autoimmune Liver Diseases: Perspectives from Japan

Springer

£80.39 13 Apr 2026
Metabolic Aspects of Chronic Liver Disease
97% match

Metabolic Aspects of Chronic Liver Disease

£139.50 08 Mar 2026
Nutrition, Diet Therapy, and the Liver
97% match

Nutrition, Diet Therapy, and the Liver

CRC Press

£77.10 03 Jul 2026
Cholestatic Liver Disease (Clinical Gastroenterology)
97% match

Cholestatic Liver Disease (Clinical Gastroenterology)

Humana

£92.56 13 Apr 2026
Hepatology (Mount Sinai Expert Guides)
97% match

Hepatology (Mount Sinai Expert Guides)

Wiley

£55.98 08 Mar 2026
The Liver in Systemic Disease: A Clinician's Guide to Abnormal Liver Tests
97% match

The Liver in Systemic Disease: A Clinician's Guide to Abnormal Liver Tests

Wiley-Blackwell

£77.86 17 Mar 2026
Autoimmune Hepatitis: A Guide for Practicing Clinicians (Clinical Gastroenterology)
97% match

Autoimmune Hepatitis: A Guide for Practicing Clinicians (Clinical Gastroenterology)

Humana

£84.55 07 Mar 2026
Mitochondria in Liver Disease: 39 (Oxidative Stress and Disease)
97% match

Mitochondria in Liver Disease: 39 (Oxidative Stress and Disease)

CRC Press

£64.09 03 Jul 2026
Maladies du foie et des voies biliaires chez l'enfant - N° 27
97% match

Maladies du foie et des voies biliaires chez l'enfant - N° 27

DOIN EDITEURS

£67.95 06 Jul 2026
Viruses and Liver Cancer (Volume 6) (Perspectives in Medical Virology, Volume 6)
96% match

Viruses and Liver Cancer (Volume 6) (Perspectives in Medical Virology, Volume 6)

Elsevier

£87.00 06 Jul 2026
Liver Disease in Clinical Practice
96% match

Liver Disease in Clinical Practice

Springer

£45.86 04 Jul 2026
Hepatocellular Carcinoma: Diagnosis and Treatment (Current Clinical Oncology)
96% match

Hepatocellular Carcinoma: Diagnosis and Treatment (Current Clinical Oncology)

Springer

£106.57 15 Apr 2026
NASH and NAFLD, An Issue of Clinics in Liver Disease (Volume 22-1) (The Clinics: Internal Medicine, Volume 22-1)
96% match

NASH and NAFLD, An Issue of Clinics in Liver Disease (Volume 22-1) (The Clinics: Internal Medicine, Volume 22-1)

Elsevier

£69.07 02 Jul 2026
Liver Pathology, An Issue of Gastroenterology Clinics of North America (Volume 46-2) (The Clinics: Internal Medicine, Volume 46-2)
96% match

Liver Pathology, An Issue of Gastroenterology Clinics of North America (Volume 46-2) (The Clinics: Internal Medicine, Volume 46-2)

Elsevier

£62.19 16 Apr 2026
Diseases of the Liver and Bile Ducts: A Practical Guide to Diagnosis and Treatment (Current Clinical Practice)
96% match

Diseases of the Liver and Bile Ducts: A Practical Guide to Diagnosis and Treatment (Current Clinical Practice)

Humana

£99.78 16 Apr 2026
Consultations in Liver Disease, An Issue of Clinics in Liver Disease: Volume 27-1 (The Clinics: Internal Medicine, Volume 27-1)
96% match

Consultations in Liver Disease, An Issue of Clinics in Liver Disease: Volume 27-1 (The Clinics: Internal Medicine, Volume 27-1)

Elsevier

£65.98 04 Jul 2026
Basic and Clinical Hepatology: 2 (Developments in Gastroenterology, 2)
96% match

Basic and Clinical Hepatology: 2 (Developments in Gastroenterology, 2)

Springer

£86.43 02 Jul 2026
Acute Liver Failure, An Issue of Clinics in Liver Disease (Volume 22-2) (The Clinics: Internal Medicine, Volume 22-2)
96% match

Acute Liver Failure, An Issue of Clinics in Liver Disease (Volume 22-2) (The Clinics: Internal Medicine, Volume 22-2)

Elsevier

£67.78 06 Jul 2026